Table 1. The demographic and clinical characteristics of subjects.
| Characteristics | TB (n = 25) | HC (n = 17) |
| Male/female | 13/12 | 9/8 |
| Age (years) | 45 (23–67) | 48 (28–68) |
| Blood | ||
| WBC (×109/l) | 5.56 (4.1–13.45) | 5.88 (4.35–8.2) |
| Monocytes (×109/l) | 0.58 (0.23–1.09) * | 0.44 (0.2–0.62) |
| Neutrophils (×109/l) | 3.91 (2.6–10.66) | 3.8 (1.86–6.07) |
| Lymphocytes (×109/l) | 1.17 (1.03–2.1) * | 1.62 (0.88–2.08) |
| Pleural fluid | ||
| WBC (×109/l) | 2.34 (0.65–5.12) | - |
| Mononuclear cells (%) | 80 (60–90) | - |
| CEA (ng/ml) | 1.69 (0.46–5.8) | - |
| DH (U/L) | 375 (192–1249) | - |
| ADA (U/L) | 52.6 (3.5–113.2) | - |
| ESR (mm/h) | 53 (15–135) * | 5 (3–21) |
| ESAT-6-specific IFN-γ secreting T cells (SFCs/2.5×105PBMC) | 10 (3–50) * | 0 (0–3) |
| CFP-10-specific IFN-γ secreting T cells (SFCs/2.5×105PBMC) | 12 (4–50) * | 0 (0–4) |
Data shown are median (range) of each group of subjects. WBC: White blood cell; CEA: Carcino-embryonic antigen; LDH: Lactate dehydrogenase; ADA: Adenosine aminhydrolase. *p<0.05 vs. the HC.